MENU
+Compare
CALC
Stock ticker: NASDAQ
AS OF
Jul 18 closing price
Price
$3.01
Change
+$0.49 (+19.44%)
Capitalization
42.06M

CALC CalciMedica Forecast, Technical & Fundamental Analysis

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage... Show more

CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CALC with price predictions
Jul 18, 2025

CALC's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CALC turned positive on July 07, 2025. Looking at past instances where CALC's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 10, 2025. You may want to consider a long position or call options on CALC as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CALC moved above its 50-day moving average on July 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CALC crossed bullishly above the 50-day moving average on July 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where CALC advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CALC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CALC broke above its upper Bollinger Band on July 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CALC entered a downward trend on July 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CALC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.862) is normal, around the industry mean (18.109). P/E Ratio (0.297) is within average values for comparable stocks, (58.647). CALC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.773).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CALC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CALC is expected to report earnings to rise 27.78% to -46 cents per share on May 10

CalciMedica CALC Stock Earnings Reports
Q1'23
Est.
$-0.46
Q1'25
Beat
by $1.11
Q4'24
Beat
by $0.65
Q4'22
Beat
by $0.08
Q3'22
Missed
by $0.05
The last earnings report on May 14 showed earnings per share of -36 cents, beating the estimate of -147 cents. With 297.33K shares outstanding, the current market capitalization sits at 42.06M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
505 Coast Boulevard South
Phone
+1 858 952-5500
Employees
14
Web
https://www.graybug.vision
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDRE32.640.42
+1.30%
Cadre Holdings
HON236.54-1.83
-0.77%
Honeywell International
CGTX0.65-0.03
-3.82%
Cognition Therapeutics
CSAN4.23-0.20
-4.51%
Cosan SA
MTA3.78-0.23
-5.74%
Metalla Royalty & Streaming Ltd

CALC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CALC has been loosely correlated with THAR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CALC jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
+19.44%
THAR - CALC
34%
Loosely correlated
+2.42%
PRRUF - CALC
26%
Poorly correlated
N/A
CNSP - CALC
25%
Poorly correlated
-10.71%
PCSA - CALC
22%
Poorly correlated
+0.38%
IMMP - CALC
22%
Poorly correlated
+0.59%
More